Non-paraneoplastic related retinopathy: clinical challenges and review.
Takiuti JT, Takahashi VKL, Xu CL, Jauregui R, Tsang SH.
Ophthalmic Genet. 2019 Aug;40(4):293-297. doi: 10.1080/13816810.2019.1650072. Epub 2019 Aug 8.
[Paraneoplastic retinopathy].
Liu Y, Lei B.
Zhonghua Yan Ke Za Zhi. 2012 Jul;48(7):653-6.
Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management.
Rahimy E, Sarraf D.
Surv Ophthalmol. 2013 Sep-Oct;58(5):430-58. doi: 10.1016/j.survophthal.2012.09.001.
Cancer-Associated Retinopathy.
Singh D, Tripathy K.
2024 Feb 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Paraneoplastic Autoimmune Retinopathy Associated With Non-IgM Lymphoplasmacytic Lymphoma.
Thomson AC, Raviskanthan S, Mortensen PW, Hogan RN, Lee AG.
J Neuroophthalmol. 2023 Dec 1;43(4):e184-e187. doi: 10.1097/WNO.0000000000001450. Epub 2021 Nov 19.
[Paraneoplastic retinopathy and optic neuropathy].
Ikawa M, Kuriyama M.
Brain Nerve. 2010 Apr;62(4):371-6.
[Paraneoplastic ophthalmopathies].
Böcskei Z, Viinikka E, Dormegny L, Bigaut K, Speeg C.
J Fr Ophtalmol. 2022 Jan;45(1):119-136. doi: 10.1016/j.jfo.2021.08.002. Epub 2021 Sep 29.
Melanoma-associated retinopathy.
Elsheikh S, Gurney SP, Burdon MA.
Clin Exp Dermatol. 2020 Mar;45(2):147-152. doi: 10.1111/ced.14095. Epub 2019 Nov 19.
Autoimmune retinopathy.
Grange L, Dalal M, Nussenblatt RB, Sen HN.
Am J Ophthalmol. 2014 Feb;157(2):266-272.e1. doi: 10.1016/j.ajo.2013.09.019. Epub 2013 Sep 29.
Paraneoplastic vision loss.
Tajfirouz D, Chen JJ.
Handb Clin Neurol. 2024;200:203-210. doi: 10.1016/B978-0-12-823912-4.00003-7.
